218 related articles for article (PubMed ID: 29842969)
1. Serglycin promotes breast cancer cell aggressiveness: Induction of epithelial to mesenchymal transition, proteolytic activity and IL-8 signaling.
Bouris P; Manou D; Sopaki-Valalaki A; Kolokotroni A; Moustakas A; Kapoor A; Iozzo RV; Karamanos NK; Theocharis AD
Matrix Biol; 2018 Dec; 74():35-51. PubMed ID: 29842969
[TBL] [Abstract][Full Text] [Related]
2. Tumorigenic functions of serglycin: Regulatory roles in epithelial to mesenchymal transition and oncogenic signaling.
Manou D; Karamanos NK; Theocharis AD
Semin Cancer Biol; 2020 May; 62():108-115. PubMed ID: 31279836
[TBL] [Abstract][Full Text] [Related]
3. Estrogen receptor alpha mediates epithelial to mesenchymal transition, expression of specific matrix effectors and functional properties of breast cancer cells.
Bouris P; Skandalis SS; Piperigkou Z; Afratis N; Karamanou K; Aletras AJ; Moustakas A; Theocharis AD; Karamanos NK
Matrix Biol; 2015 Apr; 43():42-60. PubMed ID: 25728938
[TBL] [Abstract][Full Text] [Related]
4. Serglycin is implicated in the promotion of aggressive phenotype of breast cancer cells.
Korpetinou A; Skandalis SS; Moustakas A; Happonen KE; Tveit H; Prydz K; Labropoulou VT; Giannopoulou E; Kalofonos HP; Blom AM; Karamanos NK; Theocharis AD
PLoS One; 2013; 8(10):e78157. PubMed ID: 24205138
[TBL] [Abstract][Full Text] [Related]
5. Serglycin activates pro-tumorigenic signaling and controls glioblastoma cell stemness, differentiation and invasive potential.
Manou D; Bouris P; Kletsas D; Götte M; Greve B; Moustakas A; Karamanos NK; Theocharis AD
Matrix Biol Plus; 2020 May; 6-7():100033. PubMed ID: 33543029
[TBL] [Abstract][Full Text] [Related]
6. Estrogen receptor beta as epigenetic mediator of miR-10b and miR-145 in mammary cancer.
Piperigkou Z; Franchi M; Götte M; Karamanos NK
Matrix Biol; 2017 Dec; 64():94-111. PubMed ID: 28797712
[TBL] [Abstract][Full Text] [Related]
7. Targeting Serglycin Prevents Metastasis in Murine Mammary Carcinoma.
Roy A; Femel J; Huijbers EJ; Spillmann D; Larsson E; Ringvall M; Olsson AK; Åbrink M
PLoS One; 2016; 11(5):e0156151. PubMed ID: 27223472
[TBL] [Abstract][Full Text] [Related]
8. The Expression of Serglycin Is Required for Active Transforming Growth Factor β Receptor I Tumorigenic Signaling in Glioblastoma Cells and Paracrine Activation of Stromal Fibroblasts via CXCR-2.
Manou D; Golfinopoulou MA; Alharbi SND; Alghamdi HA; Alzahrani FM; Theocharis AD
Biomolecules; 2024 Apr; 14(4):. PubMed ID: 38672477
[TBL] [Abstract][Full Text] [Related]
9. Estrogen receptor beta modulates breast cancer cells functional properties, signaling and expression of matrix molecules.
Piperigkou Z; Bouris P; Onisto M; Franchi M; Kletsas D; Theocharis AD; Karamanos NK
Matrix Biol; 2016 Dec; 56():4-23. PubMed ID: 27179695
[TBL] [Abstract][Full Text] [Related]
10. Serglycin is a theranostic target in nasopharyngeal carcinoma that promotes metastasis.
Li XJ; Ong CK; Cao Y; Xiang YQ; Shao JY; Ooi A; Peng LX; Lu WH; Zhang Z; Petillo D; Qin L; Bao YN; Zheng FJ; Chia CS; Iyer NG; Kang TB; Zeng YX; Soo KC; Trent JM; Teh BT; Qian CN
Cancer Res; 2011 Apr; 71(8):3162-72. PubMed ID: 21289131
[TBL] [Abstract][Full Text] [Related]
11. VEGF/NRP-1axis promotes progression of breast cancer via enhancement of epithelial-mesenchymal transition and activation of NF-κB and β-catenin.
Luo M; Hou L; Li J; Shao S; Huang S; Meng D; Liu L; Feng L; Xia P; Qin T; Zhao X
Cancer Lett; 2016 Apr; 373(1):1-11. PubMed ID: 26805761
[TBL] [Abstract][Full Text] [Related]
12. Proteoglycan serglycin promotes non-small cell lung cancer cell migration through the interaction of its glycosaminoglycans with CD44.
Guo JY; Chiu CH; Wang MJ; Li FA; Chen JY
J Biomed Sci; 2020 Jan; 27(1):2. PubMed ID: 31898491
[TBL] [Abstract][Full Text] [Related]
13. Serglycin secretion is part of the inflammatory response in activated primary human endothelial cells in vitro.
Reine TM; Vuong TT; Jenssen TG; Kolset SO
Biochim Biophys Acta; 2014 Aug; 1840(8):2498-505. PubMed ID: 24513305
[TBL] [Abstract][Full Text] [Related]
14. Extracellular serglycin upregulates the CD44 receptor in an autocrine manner to maintain self-renewal in nasopharyngeal carcinoma cells by reciprocally activating the MAPK/β-catenin axis.
Chu Q; Huang H; Huang T; Cao L; Peng L; Shi S; Zheng L; Xu L; Zhang S; Huang J; Li X; Qian C; Huang B
Cell Death Dis; 2016 Nov; 7(11):e2456. PubMed ID: 27809309
[TBL] [Abstract][Full Text] [Related]
15. Serglycin in tumor microenvironment promotes non-small cell lung cancer aggressiveness in a CD44-dependent manner.
Guo JY; Hsu HS; Tyan SW; Li FY; Shew JY; Lee WH; Chen JY
Oncogene; 2017 Apr; 36(17):2457-2471. PubMed ID: 27819672
[TBL] [Abstract][Full Text] [Related]
16. MCP-1-induced ERK/GSK-3β/Snail signaling facilitates the epithelial-mesenchymal transition and promotes the migration of MCF-7 human breast carcinoma cells.
Li S; Lu J; Chen Y; Xiong N; Li L; Zhang J; Yang H; Wu C; Zeng H; Liu Y
Cell Mol Immunol; 2017 Jul; 14(7):621-630. PubMed ID: 26996066
[TBL] [Abstract][Full Text] [Related]
17. Sohlh2 suppresses epithelial to mesenchymal transition in breast cancer via downregulation of IL-8.
Ji S; Zhang W; Zhang X; Hao C; Hao A; Gao Q; Zhang H; Sun J; Hao J
Oncotarget; 2016 Aug; 7(31):49411-49424. PubMed ID: 27384482
[TBL] [Abstract][Full Text] [Related]
18. Acquisition of epithelial-mesenchymal transition phenotype in the tamoxifen-resistant breast cancer cell: a new role for G protein-coupled estrogen receptor in mediating tamoxifen resistance through cancer-associated fibroblast-derived fibronectin and β1-integrin signaling pathway in tumor cells.
Yuan J; Liu M; Yang L; Tu G; Zhu Q; Chen M; Cheng H; Luo H; Fu W; Li Z; Yang G
Breast Cancer Res; 2015 May; 17(1):69. PubMed ID: 25990368
[TBL] [Abstract][Full Text] [Related]
19. The monoamine oxidase-A inhibitor clorgyline promotes a mesenchymal-to-epithelial transition in the MDA-MB-231 breast cancer cell line.
Satram-Maharaj T; Nyarko JN; Kuski K; Fehr K; Pennington PR; Truitt L; Freywald A; Lukong KE; Anderson DH; Mousseau DD
Cell Signal; 2014 Dec; 26(12):2621-32. PubMed ID: 25152370
[TBL] [Abstract][Full Text] [Related]
20. Livin promotes progression of breast cancer through induction of epithelial-mesenchymal transition and activation of AKT signaling.
Li F; Yin X; Luo X; Li HY; Su X; Wang XY; Chen L; Zheng K; Ren GS
Cell Signal; 2013 Jun; 25(6):1413-22. PubMed ID: 23524337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]